Clinical Trials

Carcinoid Tumor, Serotonin Syndrome

NCT07389512 2026-02-05

PharmTRT

EndocrineGenitourinaryHead & Neck

600 enrolled

Carcinoid Tumor, Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms

NCT02826928 2026-01-21

Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors

Phase NA Completed

116 enrolled

Carcinoid Tumor

NCT05477576 2026-01-20

ACTION-1

Phase 3 Recruiting

288 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT07317713 2026-01-05

A Two-decade Mortality Risk Analysis of Gastrointestinal Carcinoid Neoplasms: an Updated SEER-based Study 2000-2022

93,481 enrolled

Carcinoid Tumor

NCT07317726 2026-01-05

Recent Trends in Stage Migration of Gastrointestnial Carcinoid Tumors Over Two Decades: a Retrospective SEER-based Analysis 2000-2022

93,481 enrolled

Carcinoid Tumor

NCT07291752 2025-12-18

The Risk of Second Primary Gastrointestinal Malignancies Following Primary Gastrointestinal Carcinoid Tumors: a SEER Based Study 2000-2022

93,481 enrolled

Carcinoid Tumor, Neoplasms, Neoplasms, Second Primary

NCT04086485 2025-12-17

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

Phase 1/2 Recruiting

56 enrolled

EndocrineGenitourinaryNET

Carcinoid Tumor, Neuroendocrine Tumors

NCT05263050 2025-12-03

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

Phase 2 Recruiting

111 enrolled

Clear-cell metastatic renal cell carcinoma, Carcinoid Tumor, Carcinoma, Renal Cell, Neuroendocrine Tumors

NCT02270567 2025-11-13

RegisterNET

Enrolling by invitation

400 enrolled

Phase 2 Active not recruiting

Carcinoid Tumor, Carcinoma, Neuroendocrine, Neuroendocrine Tumors, Disease Progression

NCT05361668 2025-10-31

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

36 enrolled 19 charts

EndocrineGastrointestinalGynecologicHead & NeckNETThoracic

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT06790706 2025-10-06

IMMUNORARE5

Phase 2 Recruiting

154 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Thymoma, Gestational Trophoblastic Disease, Thyroid Carcinoma, Anaplastic

NCT02628067 2025-09-22

KEYNOTE 158

Phase 2 Active not recruiting

1,609 enrolled 5 FDA

EndocrineGastrointestinalGynecologicHead & NeckNETOther solid neoplasmThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Anus Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoid Tumor, Uterine Cervical Neoplasms, Mesothelioma, Parotid Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Vulvar Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Neuroendocrine Tumors, Microsatellite Instability, Small Cell Lung Carcinoma

NCT07161882 2025-09-16

SAFRO2202

Phase 1 Not yet recruiting

3,750 enrolled

EndocrineThoracic

Carcinoid Tumor, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell

NCT07165132 2025-09-10

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

104 enrolled

CNSDermatologicEndocrineNETThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT03583528 2025-06-13

DOTATOC PET/CT for Imaging NET Patients

Active not recruiting

800 enrolled

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

NCT06981455 2025-05-20

LIFENETS

246 enrolled

Phase NA Active not recruiting

Carcinoid Tumor, Neoplasms

NCT05064514 2025-05-01

TRICAR

15 enrolled

Carcinoid Heart Disease, Carcinoid Tumor, Tricuspid Valve Insufficiency, Serotonin Syndrome

NCT02795858 2025-02-19

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

43 enrolled 11 charts

Carcinoid Tumor

NCT04524442 2025-01-24

Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

Phase 4 Completed

42 enrolled 11 charts

Phase 2 Active not recruiting

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Neuroendocrine Tumors

NCT02754297 2024-08-21

P-PRRT

275 enrolled

Carcinoid Tumor, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06472388 2024-06-25

EVENET

Phase 2 Recruiting

100 enrolled

Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors, Disease Progression

NCT01398306 2024-05-06

BANN

EndocrineGenitourinaryNET

40 enrolled

Adenocarcinoma, Carcinoid Tumor, Carcinoma, Carcinoma, Renal Cell, Adenoma, Islet Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Urogenital Neoplasms, Urologic Neoplasms, Neuroendocrine Tumors

NCT01466036 2024-03-05

Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

61 enrolled 9 charts

Carcinoid Tumor, Adenoma, Islet Cell, Neoplasm Metastasis

NCT03420521 2024-01-09

Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors

Phase 2 Terminated

9 enrolled 17 charts

Carcinoid Tumor, Neuroendocrine Tumors

NCT02318784 2023-12-05

Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers

62 enrolled 10 charts

Carcinoid Tumor, Carcinoma, Neuroendocrine

NCT02859064 2023-12-05

Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres

Phase 2 Terminated

6 enrolled 12 charts

Carcinoid Tumor, Gastrointestinal Neoplasms, Neuroendocrine Tumors

NCT00657332 2023-11-28

Clinical and Pathologic Studies in Neuroendocrine Tumors

Withdrawn

Carcinoid Tumor, Neuroendocrine Tumors

NCT05448157 2023-09-22

RGS-GEP-NET

Unknown

20 enrolled

Phase EARLY_PHASE1 Withdrawn

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell

NCT03623984 2023-09-11

Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers

Carcinoid Tumor, Neuroendocrine Tumors

NCT01782443 2023-08-14

Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors

19 enrolled 11 charts

Carcinoid Tumor, Neoplasm Metastasis

NCT00442533 2023-04-03

Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors

Phase 2/3 Completed

200 enrolled

CNSEndocrineNET

Carcinoid Tumor, Paraganglioma, Pheochromocytoma, Somatostatinoma, Neuroendocrine Tumors

NCT01253161 2023-03-06

Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)

29 enrolled 11 charts

Carcinoid Tumor, Carcinoma, Neoplasm Metastasis, Neuroendocrine Tumors

NCT04915144 2023-02-21

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs

Phase 2 Withdrawn

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Vipoma, Insulinoma, Gastrinoma, Neuroendocrine Tumors

NCT03817866 2022-12-20

Chromogranin A as Blood Marker in Cancer Patients

EndocrineGastrointestinal

175 enrolled

Carcinoid Tumor, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00986661 2022-11-02

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

Phase 1 Unknown

78 enrolled

BreastDermatologicEndocrineGastrointestinalThoracic

Uveal Melanoma, Breast Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

NCT00774930 2022-10-14

ELECT

Phase 3 Completed

115 enrolled 17 charts

Carcinoid Tumor, Diarrhea, Flushing, Neuroendocrine Tumors, Serotonin Syndrome

NCT04672876 2021-12-17

Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors

Phase 2 Withdrawn

Carcinoid Tumor, Neuroendocrine Tumors

NCT01789281 2021-06-11

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.

Phase 4 Completed

34 enrolled 8 charts

Carcinoid Tumor, Neoplasms, Neuroendocrine Tumors

NCT01327612 2021-02-21

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

EndocrineGastrointestinalLymphoidSarcomaThoracic

12 enrolled 21 charts

Carcinoid Tumor, Carcinoma, Non-Small-Cell Lung, Lymphoma, Neoplasm Metastasis, Sarcoma, Colorectal Neoplasms

NCT04017104 2021-01-26

Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

Unknown

60 enrolled

CNSEndocrineGenitourinaryNET

Carcinoid Tumor, Neuroblastoma, Paraganglioma, Prostatic Neoplasms, Neuroendocrine Tumors

NCT01263353 2020-12-21

COOPERATE-1

Phase 1 Completed

36 enrolled

Carcinoid Tumor

NCT02441062 2020-12-21

Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors

122 enrolled 6 charts

CNSEndocrineNET

Carcinoid Tumor, Medulloblastoma, Neuroblastoma, Neuroendocrine Tumors

NCT04039516 2020-08-04

CHARRT

Phase 2 Unknown

20 enrolled

Carcinoid Heart Disease, Carcinoid Tumor, Serotonin Syndrome

NCT01039922 2020-01-23

SwissNET

1,245 enrolled

Carcinoid Tumor, Neuroendocrine Tumors

NCT02177773 2019-11-12

DOTA-TOC

Phase 1/2 Terminated

300 enrolled 5 charts

CNSEndocrineNET

Carcinoid Tumor, Neuroblastoma, Paraganglioma, Neuroendocrine Tumors

NCT00781911 2019-09-20

A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer

43 enrolled 12 charts

Carcinoid Tumor, Carcinoma, Neoplasm Metastasis, Carcinoma, Islet Cell, Neuroendocrine Tumors

NCT03057509 2019-06-21

A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors

Phase 1 Withdrawn